No Data
CytoSorbents Expands Global Footprint With Opening of New Regional Sales Subsidiary in Dubai
Health Care Equipment Supplier CytoSorbents Shares Dip Despite Projected Revenue Growth
CytoSorbents Analyst Ratings
CytoSorbents Reported Strong Q4 Results, Says D. Boral Capital
CytoSorbents Sees Q4 Product Revenue $9M-$9.2M Vs. $7.35M Last Year
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue